CORE--RADIOIMMUNOASSAY OF AND PRODUCTION OF ANTISERA

本计划项目的重点是激活素/激活素及其结合蛋白，受体和下游调节剂在调节生殖功能，细胞生长和发育中的作用。该计划的第一个目的是表征激活素-激活素/受体复合物的结构以及激活素、其受体和结合蛋白以及下游调节分子之间的物理相互作用。第二个目的是探索这些分子在细胞和系统水平上的生理和病理生理意义，并研究蛋白质表达和分泌的控制以及作用模式。这些研究需要具有适当特异性的高亲和力、高滴度抗体用于免疫沉淀、免疫印迹放射免疫测定（RIA）、免疫组织化学和/或免疫中和技术。该核心将产生和表征免疫中和技术所需的多克隆抗血清。该核心将生产和表征本计划项目所需的多克隆抗血清，以进行结构、功能和机制研究。我们将使用与载体蛋白偶联的合成肽作为免疫原来开发针对从cDNA序列或从纯化的天然产物的胰蛋白酶片段的氨基酸测序预测的基因产物的抗体。或者，使用体外细胞表达系统生产的蛋白质和由单个项目提供的蛋白质将直接注射到宿主动物中，用于生产抗血清。为了减少与目标蛋白质以外的抗原的交叉反应性，将使用共价结合至琼脂糖基凝胶的认知肽、重组蛋白或融合蛋白对所选抗血清进行免疫亲和纯化。本项目中的项目所提出的生理学和药理学研究主要依赖于我们测量各种生物液体中相关激素的能力。核心将提供垂体促性腺激素和性类固醇的RIA。核心负责确保这些检测的质量控制。核心将由C博士全面负责。Rivier（生物体液的RIA分析，10%努力）和W。Vale（抗体生产，3%努力）。核心B的抗血清生产和纯化组件的日常操作将在J. Vaughan的监督下进行（10%的工作量）。

This Program Project focuses on the role of activins/inhibins and their binding proteins, receptors and downstream modulators in the regulation of reproductive function, cellular growth and development. The first aim of this Program is to characterize the structure of activin-activin/receptor complexes and physical interactions between activin, its receptors and binding proteins, and downstream regulatory molecules. The second aim is to explore the physiologic and pathophysiologic significance of these molecules at the cellular and system levels and to study the control of protein expression and secretion as well as modes of action. These studies require high affinity, high titer antibodies of appropriate specificity for immunoprecipitation, immunoblot radioimmunoassay (RIA), Immunohistochemistry, and/or immunoneutralization techniques. This Core will produce and characterize polyclonal antisera needed by the immunoneutralization techniques. This Core will produce and characterize polyclonal antisera needed by the Projects of this Program to carry out structural, functional and mechanistic studies. We will use synthetic peptides conjugated to carrier proteins as immunogens to develop antibodies directed towards gene products predicted from the cDNA sequences or from amino acid sequencing of tryptic fragments of purified natural products. Alternatively, proteins produced using in vitro cell expression systems and provided by individual Projects will be injected directly into host animals for production of anti-sera. To reduce cross-reactivity with antigens other than the protein of interest, selected antisera will be immunoaffinity purified using the cognitive peptide, recombinant protein, or fusion protein covalently bound to an agarose- based gel. Physiologic and pharmacologic studies proposed by the Projects in this Program are critically dependent upon our ability to measure relevant hormones in a variety of biological fluids. The core will provide RIAs of pituitary gonadotropic hormones and sex steroids. The Core is responsible for ensuring quality control of these assays. The core will be under the overall responsibility of Drs. C. Rivier (RIA analysis of biological fluids, 10% effort) and W. Vale (antibody production, 3% effort). Day to day operation of the antisera production and purification component of Core B will be under the supervision of J. Vaughan (10% effort).